[Intended Use]
The COVID-19 & Influenza A/B Antigen Combined Test Kit is a rapid chromatography immunoassay kit that can be used for applicable to the simultaneous qualitative detection and differentiation of novel Coronavirus (COVID-19 Antigen), Influenza A virus, and Influenza B virus Antigen in population samples in vitro.
It is intended as an aid in the diagnosis of coronavirus infection disease (COVID-19), Influenza A virus, and/or Influenza B virus for symptomatic patients within 7 days after onset of symptoms.
This product is for professional use only.
[ABOUT COVID-19 & Influenza A/B virus]
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory
infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection. Asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue, and dry cough. Nasal congestion, runny nose, sore throat, myalgia, and diarrhea are found in a few cases. Influenza (flu) is a contagious respiratory illness caused by influenza viruses. Influenza viruses can cause mild to severe illness. Serious outcomes of the flu can result in hospitalization or death. Some people, such as older people, young children, and people with certain underlying health conditions, are at higher risk for serious flu complications. There are two main types of influenza viruses: types A and B. Both type A and B influenza viruses regularly spread among people and are responsible for seasonal flu each year. Influenza viruses can be spread to others before and after a person shows signs and symptoms of being sick.